Antimetabolite Immunosuppressant [EPC]

6443 reported adverse events

Drugs of this class: MYCOPHENILIC ACID MYCOPHENOLIC ACID

These side effects are most commonly reported by patients taking drugs of the Antimetabolite Immunosuppressant [EPC] class:

# Side effect Count
0 OFF LABEL USE 574
1 PRODUCT USE IN UNAPPROVED INDICATION 358
2 DRUG INEFFECTIVE 332
3 CYTOMEGALOVIRUS INFECTION 324
4 ACUTE KIDNEY INJURY 296
5 DIARRHOEA 279
6 DRUG INTERACTION 241
7 NEUTROPENIA 238
8 PYREXIA 238
9 COVID-19 216
See all common reactions for Antimetabolite Immunosuppressant [EPC]

Drugs of the Antimetabolite Immunosuppressant [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CUTANEOUS MALACOPLAKIA 6 0.3158
1 DIABETIC MACROANGIOPATHY 8 0.2857
2 ANORECTAL VARICES 6 0.2400
3 DONOR SPECIFIC ANTIBODY PRESENT 9 0.1698
4 MENINGOENCEPHALITIS AMOEBIC 6 0.1622
5 APOPTOSIS 32 0.1538
6 GASTROENTERITIS SAPOVIRUS 7 0.1522
7 MICROVILLOUS INCLUSION DISEASE 5 0.1471
8 URINOMA 16 0.1404
9 ISOSPORIASIS 8 0.1356
See all enriched reactions for Antimetabolite Immunosuppressant [EPC]